Executive Committee 2018 - 2020
We are pleased to announce our ISDE executive committee members.
President - Prateek Sharma
University of Kansas School of Medicine and VA Medical Center
He completed his Internal Medicine Residency at the Medical College of Wisconsin in Milwaukee and his Gastroenterology Fellowship at the University of Arizona in Tucson. Dr. Sharma’s research has focused on upper gastrointestinal diseases including Barrett’s esophagus, esophageal cancer gastroesophageal reflux disease and evaluating novel imaging techniques for upper and lower gastrointestinal diseases. He has over 300 publications including original articles and book chapters related to these topics and has presented at major national and international meetings. Dr. Sharma has recently written an invited review article on Barrett’s esophagus in the New England Journal of Medicine. He recently co-edited a book entitled “Barrett’s Esophagus & Esophageal Adenocarcinoma.”
Dr Sharma has had publications in high impact journal including the New England Journal of Medicine, Annals of Internal Medicine, Alimentary Pharmacology and Therapeutics, American Journal of Gastroenterology, Gastroenterology, Gastrointestinal Endoscopy and Gut. He serves as a reviewer for most of the major medicine and gastroenterology subspecialty journals.
Vice President - David Watson
Flinders Medical Centre
Bedford Park, Australia
Professor David Watson is a Matthew Flinders Distinguished Professor at Flinders University, Head of the Flinders University Department of Surgery and an Oesophageal and Gastric Surgeon at Flinders Medical Centre, in Adelaide, South Australia. His clinical and research interests include gastro-esophageal reflux and esophago-gastric cancer, and he leads molecular biology and population health research groups which are working to improve early detection and prevention of esophago-gastric cancer. He is a Senior Editor of the ANZ Journal of Surgery, and a member of the Editorial Boards for many international journals including the British Journal of Surgery, Journal of Gastrointestinal Surgery, and World Journal of Surgery.
Professor Watson has published more than 300 research papers, and more than 40 book chapters. He is a recipient of the highest research award from the Royal Australasian College of Surgeons, the John Mitchell Crouch Fellowship, has been awarded a prestigious James IV Travelling Fellowship, and he has been elected to Fellowship of the Australian Academy of Health and Medical Sciences.
Secretary - Sheila K. Krishnadath
Sheila K. Krishnadath
Erasmus Universiteit Rotterdam
Rotterdam, The Netherlands
Prof . Sheila K. Krishnadath is a gastroenterologist and professor at the Academic Medical Center in Amsterdam. Her major interest is in esophageal premalignant and malignant lesions. As an endoscopist she performs endoscopic ultrasonographies. She also has her own lab and research lines focused on Barrett's esophagus and esophageal adenocarcinoma. Prof. Krishnadath's work has been published in several important journals, including, Gastroenterology, GUT, and Cancer Research. The research has been funded through the Dutch Cancer Society and the European Research Council. During the past years she has been actively participating in most of the ISDE and ESDE meetings. These meetings have been highly interesting and have been excellent opportunities for the dissemination of her work, to learn from others, and most of all to meet with other society members.
Treasurer - Janusz Jankowski
Royal College of Surgeons in Ireland
Past President - Yuko Kitagawa
Dr. Kitagawa is a surgical oncologist and clinical and translational researcher, mainly in the areas of gastrointestinal cancers. He is a chair of Japan Esophageal Oncology Group and working as a principal investigator for several important nation-wide clinical studies including sentinel node mapping for gastric cancer and multimodal treatment for esophageal cancer. He is an Editor in Chief of the official journal of Japan Gastric Cancer Association and International Gastric Cancer Association, "Gastric Cancer" and an Associate Editor of the official journal of ISDE, "Diseases of the Esophagus".
Currently professor Kitagawa is working as a member of Executive Council of various important societies such as International Society for Diseases of the Esophagus (ISDE), Japan Surgical Society, Japanese Society of Clinical Oncology, Japan Esophageal Society and Japan Society for Lymphology. He is also serving as a chairman of Japan chapter of International Society of Surgery (ISS) / Société Internationale de Chirurgie (SIC).
Executive Director - Mark Ferguson
University of Chicago
Dr. Ferguson is a Professor in the Department of Surgery and the Comprehensive Cancer Center at The University of Chicago. He heads the Thoracic Surgery Service and is the Program Director for the Cardiothoracic Residency. His clinical interests include benign and malignant diseases of the esophagus and lung cancer. He specializes in minimally invasive surgery including robotic surgery. His research interests include risk assessment, risk mitigation, frailty, simulation, and surgical education. He is a Deputy Editor of the Annals of Thoracic Surgery, and is on the editorial board of the Journal of Gastrointestinal Surgery and Esophagus. He is Co-Editor of CTSNet. He is the author of more than 300 articles or chapters and has authored or edited more than 15 books.
University of Western Ontario
Hospital Universitario del Mar
Dr. Manuel Pera is Professor of Surgery and Head of the Section of Gastrointestinal Surgery of the Department of Surgery at the Hospital del Mar, Universitat Autònoma de Barcelona, Spain.
He completed his training in General and Digestive Surgery at the Hospital Clinic of Barcelona and fellowships at the Division of General Thoracic Surgery, Mayo Clinic, Rochester and the Division of General Thoracic Surgery, Hôtel-Dieu de Montreal, Canada.
His clinical interest includes benign and malignant diseases of the esophagus and stomach. His research interest includes gastroesophageal carcinogenesis, Barrett´s esophagus and prognostic markers in gastric and esophageal cancer.
He is past President of the European Society for Diseases of the Esophagus and Associate-Editor of the official journal of ISDE “Diseases of the Esophagus”. Professor Pera is also serving as coordinator of the EURECCA Upper GI Cancer in Spain.
He has authored more than 150 articles and book chapters.
University of Pennsylvania Perelman School of Medicine
Gary W. Falk, MD, MS, AGAF, is currently professor of medicine and co-director, GI Motility/Physiology Laboratory at the Hospital of the University of Pennsylvania. Dr. Falk received his under graduate and medical school training at the University of Rochester, NY, before going to George Washington University, Washington, DC, for his medical internship and residency. After a clinical and research fellowship at the University of Michigan, Ann Arbor, he was a member of the Department of Gastroenterology and hepatology at the Cleveland Clinic, OH, for more than 23 years where he was director for the Swallowing and Esophageal Center. While in Cleveland, he also received a master’s degree in clinical research from Case Western Reserve University.
He has been involved in clinical research in Barrett’s esophagus, gastroesophageal reflux disease, Helicobacter pylori, esophageal motility disorders, advanced esophageal imaging and therapeutics, and eosinophilic esophagitis that has resulted in over 150 peer reviewed publications and NIH and non-NIH grants. The most important of these themes has been in the area of early detection and prevention of esophageal cancer. Among the contributions of his research group have been a number of publications on the significance of high-grade dysplasia in Barrett’s esophagus, including biopsy forceps yield and findings of unsuspected cancer at esophagectomy, the use of cytologic sampling as an alternative to biopsy based surveillance, and the development of the concept of cytology specimens as a platform for molecular based biomarker studies. Other studies in Barrett’s esophagus have focused on epidemiologic observations related to the role of H. pylori in the disease along with issues of age and gender in the development of cancer. Collaborations with other centers have led to studies on familial risk, molecular imaging paradigms, chemoprevention, radiofrequency ablation and endomicroscopy. He has recently served as the chair of an NCI multicenter chemoprevention study examining the role of high dose proton pump inhibitor therapy in Barrett’s esophagus. He is involved in other chemoprevention trials in the NCI-funded Cancer Prevention Network. Recently, translational research studies in collaboration with basic scientists in cancer biology and pathobiology have commenced in order to study the role of inflammatory mediators in eosinophilic esophagitis and cell of origin of Barrett’s esophagus. Research in eosinophilic esophagitis is now focusing on clinical trials of novel therapeutic agents, clinical and biologic aspects of pediatric to adult transition, and participation in the Consortium of Eosinophilic Gastrointestinal Disease Researchers consortium.
Dr. Falk has served nationally through professional societies, including being a past-president of ASGE, editorial positions at journals and on grant review committees at NIH. He is a past associate editor of the American Journal of Gastroenterology and is the current editor of AGA Perspectives. He is a recipient of the Sidney Cohen University of Pennsylvania GI Fellowship Teacher of the Year Award on two occasions, AGA Distinguished Clinician Award, and AGA Imaging & Advanced Technology Section Research Mentor Award
University of Padua
Presently, he is a Professor of Gastroenterology. He is mainly interested in gastrointestinal motility including achalasia, acid peptic disorders including gastroesophageal reflux disease, Helicobacter Pylori, eosinophilic esophagitis, H2-breath tests, inflammatory bowel diseases and functional disorders (functional dyspepsia, irritable bowel syndrome). He received various prizes for his work from United European Gastroenterology Federation, OESO foundation, National Societies of Gastroenterology. He is also prominently involved in education of students, residents, fellows and peers at all levels.
West China Hospital, Sichuan University
Being an active member of ISDE since 1994, Prof. Long-Qi Chen attended most of ISDE conferences started from 1998. It was an extraordinary experience for him to witness the growing and strengthening of ISDE, now to be the most representative and impacted societies in the world dedicated on esophageal diseases. In aware of China, as a country with the high incidence and most number of patients with esophageal cancer, needs to exchange scientific results with the world, he founded Chinese Society for Diseases of the Esophagus (CSDE) in 2015. And from its beginning, CSDE became one of the 2 affiliated societies to ISDE, representing a combined initiative amongst Chinese surgeons, physicians, pathologists and scientists to study esophageal diseases. Later on, it promoted over 120 abstracts submission and 90 attendees to ISDE 2016 in Singapore. Prof. Long-Qi Chen will initiate or chair some task forces assigned by ISDE, already with experience with being enrolled in the WECC task force to define the 7th and 8th edition of TNM staging for esophageal cancer, and also in the ongoing Esodata project. He also serves in other local relevant societies in China like Esophageal Cancer Committee, Chinese Anti-Cancer Association (CACA), and Esophageal Expertise Committee, Chinese Association for Thoracic Surgeons (CATS).